RxDoctor Payments Data

Percio Gulko

Rheumatology · New York, NYNPI 1770609521

Payments from drug & device makers

What this record shows

That places this record below the midpoint for rheumatology clinicians in NY, where the typical reported total is $1,764.

No general payments reported

No drug or device maker reported general payments to this provider for 2019–2025. That is a common and unremarkable result.

$420,294in research payments, 2019–2025

Across 7 payments — averaging $60,042 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Gilead$398K
  • Amgen$22K

How this compares

$0 in reported general payments places this provider in the 5th percentile of 541 rheumatology providers in New York.

See all rheumatology providers in New York

Medicare billing

Part B allowed, 2024
$14,501
Medicare patients
57
Services billed
116

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
HumiraAdalimumab21$140,375
Humira(Cf)Adalimumab11$71,186
Xeljanz XrTofacitinib Citrate12$64,889
Ec-NaproxenNaproxen11$1,022
MethotrexateMethotrexate Sodium36$895
Duloxetine Hcl30$740
Leflunomide13$505
Prednisone39$212
Methylprednisolone14$210
Gabapentin11$111
Tramadol Hcl13$22

Paid to pharmacies, not to this prescriber.

Other rheumatology in New York

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →